Lineage Cell Therapeutics, Inc. Financial Ratios — LCTX

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-49.43	-112.09	-359.91	-152.85	-161.32	46.71	-14.24	-35.86	-11.32	-19.74	-45.66	-31.74	-31.42	-26.25	-103.36
Return on Assets (%)	-33.33	-56.7	-100.33	-54.91	-55.43	28.3	-12.65	-33.46	-10.31	-17.69	-30.46	-17.62	-19.13	-17.37	-56.27
Return on Capital (%)	- -	- -	- -	- -	- -	44.92	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	-54.59	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	95.24	74.35	72.28	57.01	56.31	84.1	90.62	78.67	72.12	50.19	63.4	95.05	92.5	96.48	99
EBITDA Margin (%)	-979.13	-1,309.45	-1,208.46	-2,171.08	-2,347.08	-2,407.19	-2,084.82	-2,663.98	-2,427.33	-3,157.57	-1,240.71	-148.22	-268.76	-219.7	-144.82
Operating Margin (%)	-1,120.98	-1,476.82	-1,346.63	-2,603.08	-2,597.04	-2,618.43	-2,268.75	-2,895.13	-2,630.31	-3,421.35	-1,263.12	-153.17	-276.5	-226.11	-149.62
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-1,106.43	-1,494.85	-1,964.03	-2,627.38	-2,472.38	826.87	-1,299.61	-3,328.39	-1,301.35	-2,836.22	-1,110.63	-175.56	-260.28	-195.62	-471.61
Profit Margin (%)	-990.74	-1,265.64	-1,533.83	-1,870.16	-1,854.42	1,490.76	-1,114.73	-3,247.88	-792.22	-2,671.28	-1,104.18	-178.69	-240.2	-195.9	-436.47
Net Income to Common Margin (%)	-990.74	-1,265.64	-1,533.83	-1,874.63	-1,870.8	1,490.76	-1,114.73	-3,247.88	-792.22	-2,671.28	-1,104.18	-178.69	-240.2	-195.9	-436.47
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	0.17	0.6	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-49.43	-112.09	-359.91	-152.59	-160.36	46.71	-14.24	-35.86	-11.32	-19.74	-45.66	-31.74	-31.42	-26.25	-103.36

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	1	5	4	2	2	5	4	3	4	3	3	2
ST Debt	- -	- -	- -	- -	- -	1	- -	- -	1	1	1	1	1	1	1
LT Debt	- -	- -	- -	- -	5	3	1	2	4	3	2	3	2	1	2
Total Debt/EBITDA	- -	- -	- -	-0.01	-0.09	-0.07	-0.04	-0.06	-0.14	-0.16	-0.06	-0.18	-0.12	-0.12	-0.11
Net Debt/EBITDA	1.36	0.2	0.16	0.69	0.7	0.37	0.98	0.62	0.26	1.31	1.15	0.52	1.47	2.19	1.94
Total Debt/EBIT	- -	- -	- -	-0.01	-0.08	-0.07	-0.04	-0.06	-0.13	-0.14	-0.06	-0.17	-0.12	-0.12	-0.11
Net Debt/EBIT	1.19	0.17	0.14	0.58	0.63	0.34	0.9	0.57	0.24	1.21	1.13	0.5	1.43	2.13	1.87
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	62.51	32.22	25.64	44	27.27	82.71	93.88	92.31	90.02	89.12	52.84	59.31	62.78	69.23	39.57
Long-Term Debt/Equity (%)	- -	- -	- -	0.75	6.5	2.18	0.71	2.12	3.55	2.67	2.17	4.09	3.34	1.77	3.61
Long-Term Debt/Capital (%)	- -	- -	- -	0.74	6.09	2.12	0.71	2.07	3.39	2.57	2.1	3.88	3.19	1.71	3.42
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.63	5.25	2	0.67	1.93	3.14	2.35	1.13	2.38	2.05	1.2	1.39
Total Debt/Equity (%)	- -	- -	- -	0.84	6.68	3.05	0.93	2.46	4.65	4.02	3.08	5.42	4.76	3.26	5.58
Total Debt/Capital (%)	- -	- -	- -	0.83	6.26	2.96	0.92	2.4	4.44	3.87	2.99	5.14	4.54	3.16	5.29
Total Debt/Total Assets (%)	- -	- -	- -	0.7	5.39	2.79	0.88	2.23	4.12	3.54	1.61	3.15	2.92	2.22	2.15
Net Debt to Equity	-53.58	-17.91	-13	-46.82	-54.4	-15.33	-22.32	-25.49	-8.54	-33.7	-61.32	-15.78	-57.14	-59.46	-94.11
Net Debt/Capital (%)	-115.41	-21.81	-14.95	-86.98	-105.77	-17.8	-28.43	-33.16	-8.88	-48.31	-146.85	-17.61	-120.01	-135.72	-820.08
EBITDA	-16	-22	-35	-42	-59	-54	-37	-38	-36	-24	-48	-22	-24	-21	-21
EBITDA-CapEx	-17	-23	-37	-43	-65	-57	-39	-41	-36	-24	-49	-22	-25	-21	-22
Operating Income (Loss)	-19	-25	-39	-51	-66	-59	-41	-41	-39	-26	-49	-23	-25	-21	-22

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	7.06	0.99	0.79	4.17	3.45	2.57	5.55	4.51	4.73	5.35	1.24	3.05	1.98	3.42	4.91
Current Ratio	7.93	1.64	1.14	4.58	3.79	2.9	6.2	5.34	8.86	5.66	2.37	3.16	2.14	3.65	5.2
Quick Ratio	7.06	0.99	0.95	4.37	3.58	2.7	5.99	5.06	8.42	5.35	2.32	3.06	2.02	3.47	4.99
CFO/Avg Current Liab	-4.83	-5.22	-5.2	-5.54	-4.56	-3.97	-3.88	-4.51	-4.8	-2.77	-0.86	0.03	-1.55	-1.45	-1.49
Common Equity/Total Assets	62.51	32.22	25.64	44	27.27	82.71	93.88	92.31	90.02	89.12	52.84	59.31	62.78	69.23	39.57
Long-Term Debt/Equity (%)	- -	- -	- -	0.75	6.5	2.18	0.71	2.12	3.55	2.67	2.17	4.09	3.34	1.77	3.61
Long-Term Debt/Capital (%)	- -	- -	- -	0.74	6.09	2.12	0.71	2.07	3.39	2.57	2.1	3.88	3.19	1.71	3.42
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.63	5.25	2	0.67	1.93	3.14	2.35	1.13	2.38	2.05	1.2	1.39
Total Debt/Equity (%)	- -	- -	- -	0.84	6.68	3.05	0.93	2.46	4.65	4.02	3.08	5.42	4.76	3.26	5.58
Total Debt/Capital (%)	- -	- -	- -	0.83	6.26	2.96	0.92	2.4	4.44	3.87	2.99	5.14	4.54	3.16	5.29
Total Debt/Total Assets (%)	- -	- -	- -	0.7	5.39	2.79	0.88	2.23	4.12	3.54	1.61	3.15	2.92	2.22	2.15
CFO/Total Liabilities	-310.97	-360.81	-190.78	-319.05	-244.57	-350.85	-339.91	-328.04	-224.49	-154.06	-28.17	2.05	-73.25	-63.78	-27.32
CFO/CapEx	-14.13	-49.1	-12.96	-55.35	-8.35	-16.76	-23.01	-9.4	-72.61	-308.64	-69.3	2.56	-42.38	-40.87	-36.24
Altman's Z-Score	33.72	-6.71	-20.48	3.56	4.11	15.08	15.87	2.65	-1.12	3.56	-1.75	-5.52	-10.47	-8.55	-5.79

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	5.13	1.81	2.39	2.96	2.92	1.83	2.73	4.82	0.15	0.58	17.17	13.74	19.04
Days Sales Outstanding	- -	- -	71.14	202.2	152.68	123.5	124.86	199.38	133.85	75.79	2,381.68	634.73	21.26	26.57	19.17
Inventory Turnover	1.64	8.16	6.78	3.76	8.29	716	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	222.14	44.75	53.85	96.96	44.02	0.51	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	0.15	0.38	0.4	0.32	0.33	0.16	0.13	0.18	0.17	0.15	0.46	0.25	0.3	0.21	0.08
Accounts Payable Turnover Days	2,397.8	951.68	916.67	1,131.71	1,104.32	2,244.7	2,749.45	1,992.39	2,120.01	2,388.14	787.59	1,488.08	1,208.42	1,761.62	4,393.75
Cash Conversion Cycle	-2,175.66	-906.93	-791.68	-832.54	-907.62	-2,120.69	-2,624.59	-1,793.01	-1,986.16	-2,312.36	1,594.09	-853.34	-1,187.16	-1,735.05	-4,374.58
Inventory to Cash Days	-222.14	-44.75	17.28	105.24	108.67	122.99	124.86	199.38	133.85	75.79	2,381.68	634.73	21.26	26.57	19.17
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	285	155	204	292	371	371	273	116	133	269	415	199	191	111	406
- Cash & Cash Equivalents	22	4	5	29	42	22	37	24	9	33	56	11	35	46	41
+ Preferred Equity and Hybrid Capital	- -	- -	- -	4	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	13	15	27	26	51	13	2	-2	-2	-1	-1	-1	-1	-1	-1
+ Total Debt	- -	- -	- -	1	5	4	2	2	5	4	3	4	3	3	2
Enterprise Value	275	165	226	293	383	365	238	86	106	231	358	144	157	64	351
Total Capital	41	24	42	63	82	134	166	95	116	99	94	76	65	80	46
Total Debt/Capital (%)	- -	- -	- -	0.83	6.26	2.96	0.92	2.4	4.44	3.87	2.99	5.14	4.54	3.16	5.29
Total Debt / EV	- -	- -	- -	- -	0.01	0.01	0.01	0.03	0.05	0.02	0.01	0.03	0.02	0.04	0.01
EV/Sales	165.27	97.72	79.04	150.28	151.33	162.02	132.67	60.47	71.76	298.37	91.98	9.77	17.53	6.75	24.14
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	135.62	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	97.57	- -	- -	- -
Diluted Market Cap	273	155	195	248	327	359	246	115	130	264	403	199	188	101	384
Diluted Enterprise Value	264	165	217	249	340	354	212	93	123	234	349	190	154	56	345
EV per Share	5.62	3.35	3.99	3.74	4.24	3.55	1.87	0.67	0.71	1.51	2.11	0.84	0.9	0.29	1.45
TTM Sales	2	2	3	2	3	2	2	1	1	1	4	15	9	9	15
TTM EBITDA	-16	-22	-35	-42	-59	-54	-37	-38	-36	-24	-48	-22	-24	-21	-21
TTM Operating Income	-19	-25	-39	-51	-66	-59	-41	-41	-39	-26	-49	-23	-25	-21	-22
TTM Cash Flow to Firm	-14	-20	-30	-39	-45	-42	-31	-31	-32	-20	-24	1	-29	-23	-19
TTM Free Cash Flow to Firm	-13	-19	-27	-38	-39	-40	-29	-28	-32	-20	-23	1	-28	-23	-18

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-21.64	-8.02	-7.17	-6.5	-8.33	-9.03	-8.43	-4.18	-4.11	-13.41	-17.36	134.96	-6.75	-4.47	-20.89
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	275	165	226	293	383	365	238	86	106	231	358	144	157	64	351
Low Price	3.55	2.67	3.15	2.21	2.2	2.02	2.1	0.66	0.53	0.58	1.55	1.02	0.9	0.48	0.37
EV/Sales	165.27	97.72	79.04	150.28	151.33	162.02	132.67	60.47	71.76	298.37	91.98	9.77	17.53	6.75	24.14
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	10.46	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-16.35	-9.97	-4.91	-5.81	-6.72	8.72	-16.86	-6.26	-13.22	-7.56	-9.46	-9.05	-10.51	-10.46	-3.74
Price/Earnings High	-27.15	-14.59	-6.2	-7.54	-10	11.62	-21.78	-8.72	-21.5	-14.61	-11.98	-16.64	-12.7	-17.32	-7.57
Price/Earnings Low	-10.11	-6.13	-3.89	-4.02	-3.7	5.86	-12.03	-1.82	-6.64	-4.22	-5.93	-6.59	-7.24	-5.17	-1.32
Price/Book Value	9.95	16.18	13.79	8.85	14.36	3.15	1.68	1.23	1.18	2.8	4.5	2.71	3.01	1.41	9.11
Price/Book Value Average	9.82	22.37	15.22	7.57	13.99	2.62	2.29	3.07	1.41	1.66	4.55	3.25	3.61	2.73	5.64
Price/Book Value High	16.31	32.72	19.24	9.83	20.84	3.49	2.96	4.28	2.29	3.2	5.76	5.97	4.36	4.53	11.41
Price/Book Value Low	6.08	13.76	12.07	5.25	7.71	1.76	1.64	0.89	0.71	0.92	2.85	2.37	2.48	1.35	1.99
Price/Tangible Book Value	28.41	-14.22	-6.5	-49.52	-47.68	3.44	1.75	1.28	2.47	7	11.96	12.46	30.84	5.23	186.5
Price/Tangible Book Value Average	28.06	-19.66	-7.17	-42.37	-46.44	2.87	2.4	3.18	2.95	4.14	12.07	14.9	37	10.13	115.47
Price/Tangible Book Value High	46.61	-28.76	-9.06	-54.97	-69.19	3.83	3.1	4.43	4.8	7.99	15.28	27.42	44.7	16.76	233.41
Price/Tangible Book Value Low	17.36	-12.09	-5.69	-29.34	-25.58	1.93	1.71	0.92	1.48	2.31	7.56	10.86	25.48	5.01	40.77
Price/Sales	164	91.28	68.23	127.33	128.97	156	137.35	81.55	87.63	341.63	103.45	13.51	21.04	10.59	26.4
Price/Sales Average	161.98	126.21	75.27	108.93	125.63	130.04	187.89	203.17	104.74	201.95	104.47	16.16	25.24	20.49	16.35
Price/Sales High	269	184.6	95.15	141.33	187.17	173.28	242.75	283.2	170.35	390.15	132.23	29.74	30.5	33.93	33.04
Price/Sales Low	100.21	77.62	59.7	75.45	69.2	87.29	134.15	59.15	52.57	112.6	65.45	11.78	17.38	10.14	5.77
Price/Cash Flow	-20.11	-7.85	-6.62	-6.38	-7.34	-8.3	-8.07	-3.74	-4.05	-13.37	-17.11	187.59	-6.59	-4.36	-20.31
Price/Cash Flow Average	-19.86	-10.86	-7.3	-5.46	-7.15	-6.92	-11.03	-9.32	-4.85	-7.9	-17.27	224.42	-7.9	-8.43	-12.58
Price/Cash Flow High	-32.99	-15.88	-9.22	-7.08	-10.65	-9.22	-14.25	-12.99	-7.88	-15.27	-21.86	412.86	-9.55	-13.96	-25.42
Price/Cash Flow Low	-12.29	-6.68	-5.79	-3.78	-3.94	-4.64	-7.88	-2.71	-2.43	-4.41	-10.82	163.54	-5.44	-4.17	-4.44
Price/Free Cash Flow Average	-21.37	-11.08	-7.91	-5.56	-8.12	-7.53	-11.53	-10.43	-4.91	-7.93	-17.53	161.45	-8.1	-8.64	-12.93
Price/Free Cash Flow High	-35.5	-16.21	-10	-7.21	-12.1	-10.03	-14.9	-14.53	-7.99	-15.32	-22.18	297.02	-9.78	-14.31	-26.14
Price/Free Cash Flow Low	-13.22	-6.82	-6.27	-3.85	-4.47	-5.05	-8.24	-3.04	-2.47	-4.42	-10.98	117.65	-5.58	-4.27	-4.57
EV/Sales Average	163.16	132.76	86.4	128.62	147.84	134.88	189.43	187.36	103.72	167.46	93.7	15.59	21.79	17.86	14.55
EV/Sales High	274.7	191.36	107.19	166.75	217.64	180.55	250.23	267.54	171.26	359.5	122.3	29.19	27.12	32.66	32.19
EV/Sales Low	98.79	84.01	70.12	89.21	83.83	89.73	129.87	43.07	50.03	76.3	53.5	11.2	13.83	6.46	3.38
EV/EBITDA Average	-16.66	-10.14	-7.15	-5.92	-6.3	-5.6	-9.09	-7.03	-4.27	-5.3	-7.55	-10.52	-8.11	-8.13	-10.05
EV/EBITDA High	-28.06	-14.61	-8.87	-7.68	-9.27	-7.5	-12	-10.04	-7.06	-11.39	-9.86	-19.69	-10.09	-14.87	-22.23
EV/EBITDA Low	-10.09	-6.42	-5.8	-4.11	-3.57	-3.73	-6.23	-1.62	-2.06	-2.42	-4.31	-7.55	-5.15	-2.94	-2.33
EV/EBIT Average	-14.56	-8.99	-6.42	-4.94	-5.69	-5.15	-8.35	-6.47	-3.94	-4.89	-7.42	-10.18	-7.88	-7.9	-9.72
EV/EBIT High	-24.51	-12.96	-7.96	-6.41	-8.38	-6.9	-11.03	-9.24	-6.51	-10.51	-9.68	-19.06	-9.81	-14.44	-21.51
EV/EBIT Low	-8.81	-5.69	-5.21	-3.43	-3.23	-3.43	-5.72	-1.49	-1.9	-2.23	-4.24	-7.31	-5	-2.86	-2.26
Last Price	5.81	3.14	3.6	3.73	4.1	3.61	2.15	0.91	0.89	1.76	2.45	1.17	1.09	0.5	1.67
High Price	9.53	6.35	5.02	4.14	5.95	4.01	3.8	3.16	1.73	2.01	3.13	2.58	1.58	1.61	2.09
Enterprise Value Average	272	225	247	250	375	304	339	265	153	129	365	229	195	170	212
Enterprise Value High	458	324	307	325	552	407	448	379	253	278	476	429	243	310	469
Enterprise Value Low	165	142	201	174	212	202	233	61	74	59	208	165	124	61	49

Shares Outstanding	49	49	57	78	90	103	127	127	150	153	169	170	175	220	243
Diluted Weighted Avg Shares	47	49	54	66	80	100	114	127	146	150	165	170	173	200	230
Basic Weighted Avg Shares	47	49	54	66	80	97	114	127	146	150	165	170	173	200	230
Revenue per Share	0.04	0.03	0.05	0.03	0.03	0.02	0.02	0.01	0.01	0.01	0.02	0.09	0.05	0.05	0.06
EBITDA per Share	-0.35	-0.45	-0.64	-0.64	-0.75	-0.56	-0.33	-0.3	-0.25	-0.16	-0.29	-0.13	-0.14	-0.1	-0.09
Operating Income per Share	-0.4	-0.51	-0.71	-0.76	-0.83	-0.61	-0.36	-0.32	-0.27	-0.18	-0.3	-0.13	-0.14	-0.11	-0.09
Basic EPS, GAAP	-0.35	-0.44	-0.81	-0.55	-0.59	0.34	-0.17	-0.36	-0.08	-0.14	-0.26	-0.15	-0.12	-0.09	-0.28
Basic EPS from Cont Ops	-0.39	-0.51	-0.98	-0.66	-0.73	0.19	-0.2	-0.37	-0.08	-0.14	-0.26	-0.16	-0.12	-0.09	-0.28
Diluted EPS, GAAP	-0.35	-0.44	-0.81	-0.55	-0.59	0.34	-0.17	-0.36	-0.08	-0.14	-0.26	-0.15	-0.12	-0.09	-0.28
Diluted EPS from Cont Ops	-0.39	-0.51	-0.98	-0.66	-0.73	0.19	-0.2	-0.37	-0.08	-0.14	-0.26	-0.16	-0.12	-0.09	-0.28
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.29	-0.4	-0.54	-0.58	-0.56	-0.43	-0.27	-0.24	-0.22	-0.13	-0.14	0.01	-0.17	-0.12	-0.08
Free Cash Flow per Basic Share	-0.31	-0.41	-0.59	-0.6	-0.63	-0.46	-0.28	-0.27	-0.22	-0.13	-0.15	- -	-0.17	-0.12	-0.08
Cash & Equivalents per Share	0.45	0.09	0.1	0.38	0.48	0.22	0.3	0.24	0.21	0.27	0.34	0.34	0.2	0.22	0.23
Book Value per Share	0.58	0.19	0.26	0.42	0.29	1.15	1.28	0.74	0.75	0.63	0.54	0.43	0.36	0.36	0.18
Tangible Book Value per Share	0.2	-0.22	-0.55	-0.08	-0.09	1.05	1.23	0.71	0.36	0.25	0.2	0.09	0.04	0.1	0.01

Lineage Cell Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)